These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21919734)

  • 1. Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting.
    Robbins RN; Remien RH; Mellins CA; Joska JA; Stein DJ
    AIDS Patient Care STDS; 2011 Oct; 25(10):587-93. PubMed ID: 21919734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of the International HIV Dementia Scale in South Africa.
    Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
    AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
    Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
    AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa.
    Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska J
    AIDS Behav; 2012 Aug; 16(6):1464-71. PubMed ID: 22001934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinako, a study on HIV competent households in South Africa: a cluster-randomised controlled trial protocol.
    Masquillier C; Knight L; Campbell L; Sematlane N; Delport A; Dube T; Wouters E
    Trials; 2020 Feb; 21(1):154. PubMed ID: 32041656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
    Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
    PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.
    Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC
    AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for HIV-Associated Neurocognitive Disorder (HAND) in Adults Aged 50 and Over Attending a Government HIV Clinic in Kilimanjaro, Tanzania. Comparison of the International HIV Dementia Scale (IHDS) and IDEA Six Item Dementia Screen.
    Kellett-Wright J; Flatt A; Eaton P; Urasa S; Howlett W; Dekker M; Kisoli A; Duijinmaijer A; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska E; Akinyemi R; Lwezuala B; Gray WK; Walker RW; Dotchin CL; Makupa P; Paddick SM
    AIDS Behav; 2021 Feb; 25(2):542-553. PubMed ID: 32875460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment and neurocognitive profiles among people living with HIV and HIV-negative individuals older over 50 years: a comparison of IHDS, MMSE and MoCA.
    Chen P; Xin X; Xiao S; Liu H; Liu X; He N; Ding Y
    J Neurovirol; 2024 Apr; 30(2):103-114. PubMed ID: 38709469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa.
    Joska JA; Westgarth-Taylor J; Myer L; Hoare J; Thomas KG; Combrinck M; Paul RH; Stein DJ; Flisher AJ
    AIDS Behav; 2011 Aug; 15(6):1197-203. PubMed ID: 20614176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive Impairment in a Chronically Well-Suppressed HIV-Infected Population: The Dutch TREVI Cohort Study.
    van den Dries LWJ; Wagener MN; Jiskoot LC; Visser M; Robertson KR; Adriani KS; van Gorp ECM
    AIDS Patient Care STDS; 2017 Aug; 31(8):329-334. PubMed ID: 28753395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Montreal Cognitive Assessment-Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa.
    Hakkers CS; Beunders AJM; Ensing MHM; Barth RE; Boelema S; Devillé WLJ; Tempelman HA; Coutinho RA; Hoepelman AIM; Arends JE; van Zandvoort MJE
    Int J Infect Dis; 2018 Feb; 67():36-40. PubMed ID: 29183843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia.
    Tsegaw M; Andargie G; Alem G; Tareke M
    J Psychiatr Res; 2017 Feb; 85():37-41. PubMed ID: 27821271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Mobile App to Screen for Neurocognitive Impairment: Preliminary Validation of NeuroScreen Among HIV-Infected South African Adults.
    Robbins RN; Gouse H; Brown HG; Ehlers A; Scott TM; Leu CS; Remien RH; Mellins CA; Joska JA
    JMIR Mhealth Uhealth; 2018 Jan; 6(1):e5. PubMed ID: 29305338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.
    Njamnshi AK; Bissek AC; Ongolo-Zogo P; Tabah EN; Lekoubou AZ; Yepnjio FN; Fonsah JY; Kuate CT; Angwafor SA; Dema F; Njamnshi DM; Kouanfack C; Djientcheu Vde P; Muna WF; Kanmogne GD
    J Neurol Sci; 2009 Oct; 285(1-2):149-53. PubMed ID: 19631349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
    Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
    J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa.
    Goodkin K; Hardy DJ; Singh D; Lopez E
    J Neuropsychiatry Clin Neurosci; 2014; 26(4):352-8. PubMed ID: 26037857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates of HIV-associated neurocognitive disorders in South Africa.
    Joska JA; Fincham DS; Stein DJ; Paul RH; Seedat S
    AIDS Behav; 2010 Apr; 14(2):371-8. PubMed ID: 19326205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding a brief self-report cognitive tool to the IHDS improves effectiveness of identifying patients with HIV-associated dementia in South Africa.
    Gouse H; Casson-Crook M; Decloedt EH; Joska JA; Thomas KGF
    J Neurovirol; 2017 Oct; 23(5):686-695. PubMed ID: 28748448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.